1. Home
  2. SRRK vs LBRDK Comparison

SRRK vs LBRDK Comparison

Compare SRRK & LBRDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$46.81

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Logo Liberty Broadband Corporation Class C

LBRDK

Liberty Broadband Corporation Class C

HOLD

Current Price

$38.78

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
LBRDK
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.4B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SRRK
LBRDK
Price
$46.81
$38.78
Analyst Decision
Strong Buy
Analyst Count
13
0
Target Price
$56.17
N/A
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$534.24
$109.28
P/E Ratio
N/A
$10.10
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$36.60
52 Week High
$51.63
$104.00

Technical Indicators

Market Signals
Indicator
SRRK
LBRDK
Relative Strength Index (RSI) 47.90 31.41
Support Level $45.59 N/A
Resistance Level $47.96 $50.21
Average True Range (ATR) 1.67 3.12
MACD -0.35 -1.59
Stochastic Oscillator 25.92 9.77

Price Performance

Historical Comparison
SRRK
LBRDK

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About LBRDK Liberty Broadband Corporation Class C

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

Share on Social Networks: